Disclaimer: This is a simplified summary of a public company filing. See full disclaimer here.

Resonate Blends, Inc.

CIK: 8970782 Annual ReportsLatest: 2025-06-10

10-K / June 10, 2025

Revenue:$1,349,905
Income:-$1,555,767

10-K / April 16, 2024

Revenue:$16,468
Income:-$1,415,979

10-K / June 10, 2025

Company Summary: Resonate Blends, Inc.

Business Focus and Operations

  • Core Business: Engages in the discovery, development, and marketing of products aimed at improving human health and performance.
  • Market Position: Positioning as a leader in the field of Regenerative Medicine, as defined by the NIH, utilizing nutritionally designed products.
  • Product Marketing: Aiming to market products under third-party label exemptions.

Key Products and R&D

  • Natural Stem Cell Mobilizing Agents: Licensed patent-pending products designed to enhance individuals’ ability to mobilize their own adult stem cells from bone marrow.
  • Natural Diet Aids: Licensed under a patent-pending application, these dual-acting all-natural diet aids help control hunger using body signals to the brain and stomach.
  • Research Focus: Exploring bioactive formulations such as Secretogues to naturally enhance growth hormone production and human performance without drugs.

Market Segments

  • Consumer Market: Products aimed at individual health enhancement.
  • Professional Market: Products adapted for use by health professionals.

Customer and Market Data

  • Number of Customers: Not explicitly provided.
  • Revenue:
    • For the nine months ending September 30, 2024, revenue was approximately $1,349,905 (unaudited); all of this was attributable to EMGE (acquired in March 2024).
    • For the nine months ending September 30, 2023, revenue was approximately $16,468 (unaudited); attributable to the subsidiary before acquisition.
  • Income:
    • Net loss for the nine months ending September 30, 2024: $1,555,767 (unaudited).
    • Net loss for the same period in 2023: $1,011,432 (unaudited).

Employees

  • Staffing: No specific number of employees is provided; management states there are no significant employees.

Additional Details

  • Growth and Development: Focused on expanding marketing and R&D in bioactive and performance-enhancing formulations.
  • Financials & Market:
    • The company is publicly traded on OTCQB under the symbol “KOAN.”
    • Stockholders' equity is negative, with a total shareholders’ deficit of approximately $3.2 million as of December 31, 2024.
    • The company has a history of incurring losses and has a significant accumulated deficit of over $28 million.
    • Has a working capital deficit of approximately $3.5 million as of December 31, 2024.
    • Relies on convertible debt, loans, and external financing for operations.

Summary

Resonate Blends, Inc. is a biotech and nutraceutical company involved in developing natural, patent-pending products aimed at stem cell activation and appetite control, targeting health-conscious consumers and professionals. It is active in R&D for performance and growth hormone enhancement, with recent revenue driven mainly by its acquisition of EMGE. The company faces financial challenges, including ongoing losses and a significant deficit, and is in the process of expanding its product offerings and market penetration.